Prescription drug · ANDA
Busulfan NDC 0409-1112
Busulfan 6 mg/mL · Injection, Solution · Intravenous · Hospira, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0409-1112-01 | 0040911120100409111201 | 8 CARTON in 1 CARTON (0409-1112-01) / 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1112-10) / 10 mL in 1 VIAL, SINGLE-DOSEMarketed from Feb 28, 2019 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Busulfan
- Generic name (nonproprietary)
- busulfan
- Active ingredients
- Busulfan — 6 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Hospira, Inc.NDC labeler code 0409
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205672
- Marketing start
- Listing expires
- Other FDA classes
- Alkylating Activity (Mechanism)
- Identifiers
- Product ID 0409-1112_1e2080b5-8c77-4eb1-95bf-4cbd86c27995SPL ID 1e2080b5-8c77-4eb1-95bf-4cbd86c27995SPL set ID b9c7f0dc-988d-466e-8031-400ec4f60f21RxCUI 253113UNII G1LN9045DK
- Pharmacologic class
- Alkylating Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400409111201followed by a unit qualifier and the quantityPackage 00409-1112-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Busulfan Injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia. Busulfan Injection is an alkylating drug indicated for: Use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia (CML). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0409-1112
- What is NDC 0409-1112?
- 0409-1112 is the product NDC for Busulfan, Busulfan 6 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Busulfan.
- What is the active ingredient?
- Busulfan.
- Who is the labeler?
- Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Busulfan?
- 7 other product NDCs are listed under this name. See all Busulfan NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Busulfan products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Busulfan | Busulfan 6 mg/mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-395 | 55150-0395-08 |
| Busulfan | Busulfan 6 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-116 | 71288-0116-11 |
| Busulfan | Busulfan 6 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-158 | 71288-0158-96 |
| Busulfan | Busulfan 6 mg/mL | InjectionIntravenous | Accord Healthcare, Inc | 16729-351 | 16729-0351-92 |
| Busulfan | Busulfan 6 mg/mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1244 | 70121-1244-07 |
| Busulfan | Busulfan 6 mg/mL | InjectionIntravenous | Pharmascience Inc. | 51817-170 | 51817-0170-01 |
| Busulfan | Busulfan 6 mg/mL | Injection, Solution, ConcentrateIntravenous | Sagent Pharmaceuticals | 25021-241 | 25021-0241-10 |